Vaginal application of a chemotherapeutic agent before legal abortion. A way of reducing infectious complication?
In an attempt to reduce the incidence of infectious complications after first trimester legal abortion 199 healthy, early pregnant women were treated with chloroquinaldol (SterosanR vaginal jelly) during six days before their vacuum aspiration. A group of 291 women served as control. In the treatment group 18 women (9%) had a postoperative gynecological infection while this condition was found in 37 women (12.8%) in the control group. This difference is not statistically significant. The authors conclude that preoperative prophylactic treatment with Sterosan vaginal jelly does not seem to reduce postoperative infectious complications after first trimester legal abortions.
D000028:Abortion, Induced; D000328:Adult; D002750:Chlorquinaldol / Q000627:therapeutic use*; D004107:Dilatation and Curettage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000517:prevention & control*; D011247:Pregnancy; D014619:Vacuum Curettage / Q000009:adverse effects*; D014622:Vaginal Creams, Foams, and Jellies
D014622:Vaginal Creams, Foams, and Jellies; D002750:Chlorquinaldol